Zhen Kang

Zhen Kang

Auto-generated profile, based on publicly available information

Zhen Kang

The Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Metabolic Engineering
Verified
Journal Article
Closed access
PJPeng Jin
Peng Jin
ZKZhen Kang
Zhen Kang
PYPanhong Yuan
Panhong Yuan
GDGuocheng Du
Guocheng Du
Jian ChenJian Chen
Jian Chen

14 February 2017 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
SYSen Yang
Sen Yang
GDGuocheng Du
Guocheng Du
Jian ChenJian Chen
Jian Chen
ZKZhen Kang
Zhen Kang

26 February 2015 in Scientific Reports
Verified
Journal Article
Open access
JZJunli Zhang
Junli Zhang
ZKZhen Kang
Zhen Kang
JCJian Chen
Jian Chen
GDGuocheng Du
Guocheng Du
5-Aminolevulinic acid (ALA), the committed intermediate of the heme biosynthesis pathway, shows significant promise for cancer treatment. Here, we identified that in addition to hemA and hemL, hemB, hemD, hemF, hemG and hemH are also the major regulatory targets of the heme biosynthesis pathway. Interestingly, up-regulation of hemD and hemF benefited ALA accumulation whereas overexpression of hemB, hemG and hemH diminished ALA accumulation. Accordingly, by combinatorial overexpression of the hemA, hemL, hemD and hemF with different copy-number plasmids, the titer of ALA was improved to 3.25 g l−1. Furthermore, in combination with transcriptional and enzymatic analysis, we demonstrated that ALA dehydratase (HemB) encoded by hemB is feedback inhibited by the downstream intermediate protoporphyrinogen IX. This work has great potential to be scaled-up for microbial production of ALA and provides new important insights into the regulatory mechanism of the heme biosynthesis pathway.

1 April 2016 in Carbohydrate Polymers
Verified
Journal Article
Closed access
PJPeng Jin
Peng Jin
LZLinpei Zhang
Linpei Zhang
PYPanhong Yuan
Panhong Yuan
ZKZhen Kang
Zhen Kang
GDGuocheng Du
Guocheng Du
Jian ChenJian Chen
Jian Chen

19 June 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYang Wang
Yang Wang
LHLitao Hu
Litao Hu
HHHao Huang
Hao Huang
HWHao Wang
Hao Wang
TZTianmeng Zhang
Tianmeng Zhang
ZKZhen Kang
Zhen Kang
Hyaluronan is widely used in cosmetics and pharmaceutics. Development of robust and safe cell factories and cultivation approaches to efficiently produce hyaluronan is of many interests. Here, we describe the metabolic engineering of Corynebacterium glutamicum and application of a fermentation strategy to manufacture hyaluronan with different molecular weights. C. glutamicum is engineered by combinatorial overexpression of type I hyaluronan synthase, enzymes of intermediate metabolic pathways and attenuation of extracellular polysaccharide biosynthesis. The engineered strain produces 34.2 g L−1 hyaluronan in fed-batch cultures. We find secreted hyaluronan encapsulates C. glutamicum, changes its cell morphology and inhibits metabolism. Disruption of the encapsulation with leech hyaluronidase restores metabolism and leads to hyper hyaluronan productions of 74.1 g L−1. Meanwhile, the molecular weight of hyaluronan is also highly tunable. These results demonstrate combinatorial optimization of cell factories and the extracellular environment is efficacious and likely applicable for the production of other biopolymers.

26 March 2014 in Scientific Reports
Verified
Journal Article
Open access
PJPeng Jin
Peng Jin
ZKZhen Kang
Zhen Kang
NZNa Zhang
Na Zhang
GDGuocheng Du
Guocheng Du
Jian ChenJian Chen
Jian Chen
Hyaluronidases (HAases), particularly leech HAases, have attracted intense attention due to their broad applications in medical treatments and great potential for the enzymatic production of hyaluronan oligosaccharides. However, little is known about this third interesting family of HAases. Here, we applied the random amplification of cDNA ends polymerase chain reaction (RACE-PCR) approach to identify the first leech HAase-encoding gene. By combining protein engineering and high-density culture, we achieved high-level production (8.42 × 10(5) U ml(-1)) in the yeast Pichia pastoris secretory expression system. Compared with the commercial bovine testicular HAase, the recombinant leech HAase exhibited superior enzymatic properties. Furthermore, analysis of the hydrolytic process suggested that this novel enzyme adopts a nonprocessive endolytic mode, yielding a narrow-spectrum of specific HA oligosaccharides with different incubation times. Large-scale production of this novel leech HAase will not only greatly promote medical applications but also facilitate the enzymatic production of specific HA oligosaccharides.